Istituto Oncologico Veneto ( Site 0221)
Padova 35128
0 studies enrolling now · 1 studies all time
What they study most
Merkel Cell Carcinoma
Studies at this site
Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913)
— Completed